Trident Lifeline Limited IPO

Apply 0
Avoid 0

i. Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. Trident is also engaged in distribution of pharmaceutical products through third party distribution network. They offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. The company operates in India as well as African, Latin American and East Indian Countries. They have their presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela

ii. Trident Lifeline deals in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. The company’s product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). The company’s product portfolio consists of 832 products.

Company’s Core business can be divided into the following categories:

a. Ethical marketing of pharmaceutical formulation & products in International Market through third-party distribution network and sales force under own brand.

b. Getting the approved formulations manufactured through Contract Manufacturers, Source & Supply of Generic Pharma formulation and medicines in Domestic as well as International Market.

Trident Lifeline is engaged in the business of marketing pharmaceutical products. For which the company has obtained the necessary approvals from FDA for getting the manufacture of the formulation from contract manufacturers on a Loan License or on a principle-to principle basis.

Objects of the Trident Lifeline Limited IPO:

The Issue Proceeds from the Fresh Issue will be utilized for the following objects: i. To Meet Working Capital Requirements ii. Product registration in the international markets iii. General Corporate Purpose iv. To meet Public Issue Expenses
DRHP of Trident Lifeline Limited IPO
RHP of Trident Lifeline Limited IPO

Trident Lifeline Limited IPO Details:

Open Date: Sep 26 2022
Close Date: Sep 29 2022
Total Shares: 3,499,200
Face Value: ₹ 10 Per Equity Share
Issue Type: Fixed Price Issue
Issue Size: 35.34 Cr.
Lot Size: 1200 Shares
Issue Price: ₹ 101 Per Equity Share
Listing At: BSE SME
Listing Date: Oct 10 2022

Promoters And Management:

i. Mr. Hardik Jigishkumar aged 44 years is Promoter-Chairman and executive director of the Company. He was origionally appointed as additional executive director on February 26, 2015. Further, he was regularised as executive director on September 30, 2015. He resigned from the said poition on October 07, 2016. He re-joined the company and was appointed as additional executive director on October 01, 2020. He was regularised as executive director on July 04, 2022. He was designated as Chairman and executive director of the Company for the period of 3 (Three) years on June 27, 2022. He holds the Degree of Bachelor of Commerce from the South Gujarat University He is having experience of more than 8 years in the field Pharmaceutical Industries. ii. Mr. Shravan Harikrishna Patel aged 28 years is Managing Director of the Company. He was appointed as additional executive director of the Company on June 27, 2022. Subsequently regularise cum appointment as Managing Director of the company on July 04, 2022 for the period of 5 (Five) years w.e.f. June 27, 2022 liable to retire by rotation. He Holds the degree of Master of Urban and Regional Planning from CEPT University. He is having more than 3 years of Experience in Pharma Industries. iii. Mr. Mayurkumar Mansukhbhai Gajera aged 37 years is Whole Time Director of the Company. He was appointed as additional executive director of the Company on October 01, 2020. Consequently regularised cum appointment as an executive director of the Company on September 30, 2021. At present he was appointed as a Whole Time Director of the Company for a period of 3 (Three) years w.e.f. June 27, 2022 liable to retire by rotation. He holds degree of Master’s Program in Business Administration (MBA) in Marketing Management from the Indian Institute of Business Management & Studies. He is having experience of more than 3 years in the field of Pharmaceutical/herbal Industry.

Financials of Trident Lifeline Limited IPO:

Particulars (in crores) Mar-22
Revenue from operations 21
Cost of Materials Consumed 10
Purchase of Stock-in-trade 4
Changes in inventories -0.4
Employee Benifit Expense 1
Other Expense 3
Operating Profit 3.40
OPM% 16.19%
Finance Cost 0.1
Depreciation 0.2
Other Income 0.6
Profit (Loss) before tax 3
Profit (Loss) for the period 2
No of Share 1
Earnings per share 2

Comparison With Peers:

Name of the Company CMP FV EPS P/E
Trident Lifeline Limited 101 10 2 50.5
Vaishali Pharma Limited 96.2 10 3.81 21.5
Chandra bhagat Pharma limited 106 10 1.06 100

Lead Manager of Trident Lifeline Limited IPO:

  1. Beeline Broking Limited

Registrar of Trident Lifeline Limited IPO:

  1. Link Intime India Private Limited

Company Address:

Trident Lifeline Limited 2nd Floor, Shop-2004, North Extension, Falsawadi Begumpura, Nodh-4/1650, Sahara Darwaja, Surat – 395003 Phone: 8160276395 Email: compliance@tridentlifeline.com Website: http://www.tridentlifeline.com/

Discussion on Trident Lifeline Limited IPO:

Leave a Reply